GRIP Molecular Technologies
PrivateLast Round
Convertible Debt
May 30, 2023
Total Funding Raised
$8.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GRIP Molecular Technologies operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. Its latest recorded funding round was a Convertible Debt round in May 2023.
GRIP Molecular Technologies is a biotechnology company that develops CRISPR-based diagnostic platforms and electronic biosensors for rapid, point-of-need infectious disease testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Sensors
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GRIP Molecular Technologies Comparables
Compare GRIP Molecular Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapphiros | 83% | |
| Videm | 82% | |
| Nanopath | 80% |
For institutional investors. Book with your work email.
GRIP Molecular Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 30, 2023 | ||||
| Grant | Jan 31, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GRIP Molecular Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch Minnesota | Grant |
| EvoNexus | Accelerator |
| Minnesota Department of Employment and Economic Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 253% MoM, reaching 325.
- Nov 7, 2025
Monthly visitors grew 118% MoM, from 113 to 246.
For institutional investors. Book with your work email.
GRIP Molecular Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GRIP Molecular Technologies's valuation, stock price, and market status.
Is GRIP Molecular Technologies a public or private company?
GRIP Molecular Technologies is a private company.
What is the current stock price of GRIP Molecular Technologies?
GRIP Molecular Technologies is a private company, so its shares have no public market price. Caplight tracks GRIP Molecular Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GRIP Molecular Technologies worth (valuation)?
Valuation information for GRIP Molecular Technologies is not publicly available.
Can I buy GRIP Molecular Technologies stock?
GRIP Molecular Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GRIP Molecular Technologies's last funding round?
GRIP Molecular Technologies's most recent funding round was Convertible Debt on May 30, 2023.
Who are the main investors in GRIP Molecular Technologies?
Key investors in GRIP Molecular Technologies include Launch Minnesota, EvoNexus.
Will GRIP Molecular Technologies IPO soon?
No public IPO plans have been announced for GRIP Molecular Technologies.
How can I track GRIP Molecular Technologies secondary market activity?
Caplight tracks bids, offers, and trades in GRIP Molecular Technologies's shares on secondary markets.